Insider Transactions in Q3 2022 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.52%
|
$600,000
$30.91 P/Share
|
|
Aug 23
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.51%
|
$640,000
$32.02 P/Share
|
|
Aug 23
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,424
-1.4%
|
$75,144
$31.98 P/Share
|
|
Aug 19
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
2,404
-0.11%
|
$79,332
$33.22 P/Share
|
|
Aug 19
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,253
-1.49%
|
$74,349
$33.22 P/Share
|
|
Aug 19
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,576
-0.55%
|
$85,008
$33.22 P/Share
|
|
Aug 19
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,576
-1.47%
|
$85,008
$33.22 P/Share
|
|
Aug 09
2022
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+16.91%
|
-
|
|
Aug 09
2022
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+15.63%
|
-
|
|
Jul 25
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.51%
|
$700,000
$35.88 P/Share
|
|
Jul 19
2022
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+29.18%
|
$0
$0.68 P/Share
|